Answers are grounded in this paper and cite their sources.
Purpose of Review Irritable bowel syndrome (IBS) in children is a disorder of gut-brain interaction (DGBI) characterized by chronic abdominal pain related to bowel movements. This review aims to evaluate the clinical application of different therapies in pediatric IBS including current and new pharmacological and non-pharmacological treatments. Recent Findings While further pediatric data is needed in pediatrics to help optimize management, combination of pharmacologic and non-pharmacologic interventions are often used. Adult recommendations are published for the use of Linaclotide for IBS-C, tricyclic antidepressants for IBS-D. In pediatrics, CBT and hypnotherapy have been found to be successful in management of symptoms. Further evaluation is needed for the role of dietary changes and OMT. Summary Pediatric IBS may be difficult to treat and often requires both pharmacologic and non-pharmacologic management. There is no clear consensus for management of pediatric IBS and will often require implementation of adult recommendations for pediatric use. Gut directed hypnotherapy has been clearly shown to improve symptoms of IBS in children. Further studies are needed in pediatrics in the management of IBS.
No takes yet. Share an insight, caveat, or question.
Hawa et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: